These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7635039)

  • 1. The NHS drugs budget: a report by the Commons Select Committee.
    Drug Ther Bull; 1994 Aug; 32(8):64. PubMed ID: 7635039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NHS medicines bill: running out of control?
    Drug Ther Bull; 2015 Jun; 53(6):61. PubMed ID: 26045094
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmaceutical organization recommends to budget-concerned physicians: simply do without some prescriptions!].
    Vorderwulbecke U
    MMW Fortschr Med; 1999 Dec; 141(48):56. PubMed ID: 10766549
    [No Abstract]   [Full Text] [Related]  

  • 4. Health evidence in United Kingdom House of Commons Select Committee inquiries.
    Patel K
    Public Health; 2021 Dec; 201():1-7. PubMed ID: 34742111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Unfairly implicated as cost drivers. New drugs without a chance?].
    MMW Fortschr Med; 2004 Mar; 146(10):45. PubMed ID: 15347085
    [No Abstract]   [Full Text] [Related]  

  • 6. Systems for evaluation of new drugs in the United Kingdom.
    Beard K
    Pharmacoepidemiol Drug Saf; 2001; 10(5):439-43. PubMed ID: 11802590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The national health service in the United Kingdom-past, present and future].
    Nakanishi N; Tatara K
    Nihon Eiseigaku Zasshi; 1996 Oct; 51(3):657-65. PubMed ID: 8952325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specialist palliative care in the UK: its future and the effects of NHS reforms.
    Trueman I
    Int J Palliat Nurs; 2001 Apr; 7(4):198-203. PubMed ID: 11951288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Declining costs].
    Neumaier J
    MMW Fortschr Med; 2016 Jun; 158 Suppl 1():58. PubMed ID: 27259908
    [No Abstract]   [Full Text] [Related]  

  • 10. Medicines management. Fit to bust.
    Calvert R
    Health Serv J; 2002 Oct; 112(5826):24-5. PubMed ID: 12397667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Do pharmacists and the state increase drug costs?].
    Kaesback W
    MMW Fortschr Med; 1999 Dec; 141(48):54. PubMed ID: 10766548
    [No Abstract]   [Full Text] [Related]  

  • 12. The cost to the United Kingdom National Health Service of managing erectile dysfunction: the impact of sildenafil and prescribing restrictions.
    Wilson EC; McKeen ES; Scuffham PA; Brown MC; Wylie K; Hackett G
    Pharmacoeconomics; 2002; 20(13):879-89. PubMed ID: 12381240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug expenditures and health insurance contributions increase. Control of budgetsis at risk].
    Jentsch P
    MMW Fortschr Med; 2001 Jul; 143(26-27):49-50. PubMed ID: 11481918
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical economy and the economic assessment of drugs in France.
    le Pen C
    Soc Sci Med; 1997 Aug; 45(4):635-43. PubMed ID: 9226787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labour promises to end market forces in NHS.
    Nurs Stand; 2015 Feb; 29(23):8. PubMed ID: 25649553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of a shortened standardised treatment regimen of antituberculosis drugs for patients with multidrug-resistant tuberculosis (STREAM): study protocol.
    Gama E; Madan J; Langley I; Girma M; Evans D; Rosen S; Squire SB
    BMJ Open; 2016 Oct; 6(10):e014386. PubMed ID: 27798041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Health economics, pharmacoeconomics and prescriptions in dermatology].
    Berdeaux G
    Ann Dermatol Venereol; 2000 Mar; 127(3):324-8. PubMed ID: 10804314
    [No Abstract]   [Full Text] [Related]  

  • 18. [The budget control function of the Drug Reimbursement System].
    Pronk MH; Bonsel GJ; van der Kuy A
    Ned Tijdschr Geneeskd; 2002 Sep; 146(37):1729-33. PubMed ID: 12357873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Separate pharmaceutical budgets: skating on thin ice].
    Egberts AC; de Boer A
    Ned Tijdschr Geneeskd; 2010; 154(51-52):A3004. PubMed ID: 21211087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.